Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ATOS — Atossa Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$439
-$1,117 QoQ
Shares Held
228
-23.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 31 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ATOS ranks #376 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ATOS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $439 228
2026-03-31 $1,556 296
2025-12-31 $48 83
2025-09-30 $72 83
2025-06-30 $448 542
2025-03-31 $49,270 73,539
2024-12-31 $67,416 71,720
2024-09-30 $83,397 54,867
2024-06-30 $63,146 53,065
2024-03-31 $1,657 921
2023-12-31 $800 910
2023-09-30 $642 868
2023-06-30 $6,371 5,057
2023-03-31 $3,616 5,023
2022-12-31 $429 811
2022-09-30 $655 790
2022-06-30 $923 847
2022-03-31 $31,172 24,938
2021-12-31 $105,043 65,652
2021-06-30 $7,356 1,164
2021-03-31 $2,034 964
2020-12-31 $64 68
2020-09-30 $154 64
2020-06-30 $231 61
2020-03-31 $81 61